Achieve Life Sciences (ACHV) Misses Q3 EPS by 4c

Achieve Life Sciences (NASDAQ: ACHV) reported Q3 EPS of ($0.28), $0.04 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• Subaru, other Japan suppliers to team on delivery as Boeing raises output - Nikkei
• BRP Inc. (DOO) Reports Q2 Loss of Cd$0.18
• Morgan Stanley Downgrades Ultragenyx Pharma (RARE) to Equalweight